Cargando…
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kin...
Autores principales: | Maire, Virginie, Baldeyron, Céline, Richardson, Marion, Tesson, Bruno, Vincent-Salomon, Anne, Gravier, Eléonore, Marty-Prouvost, Bérengère, De Koning, Leanne, Rigaill, Guillem, Dumont, Aurélie, Gentien, David, Barillot, Emmanuel, Roman-Roman, Sergio, Depil, Stéphane, Cruzalegui, Francisco, Pierré, Alain, Tucker, Gordon C., Dubois, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658982/ https://www.ncbi.nlm.nih.gov/pubmed/23700430 http://dx.doi.org/10.1371/journal.pone.0063712 |
Ejemplares similares
-
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018) -
Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015) -
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
por: Marty, Bérengère, et al.
Publicado: (2008) -
Molecular basis underlying resistance to Mps1/TTK inhibitors
por: Koch, A, et al.
Publicado: (2016) -
Leader of the SAC: molecular mechanisms of Mps1/TTK regulation in mitosis
por: Pachis, Spyridon T., et al.
Publicado: (2018)